Pancreaticojejunostomy With or Without Modified N-butyl-2-cyanoacrylate Following Pancreaticoduodenectomy in Soft Pancreas: Randomized Controlled Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07155525

Title field or adapter rule

{'original_value': 'Pancreaticojejunostomy With or Without Modified N-butyl-2-cyanoacrylate Following Pancreaticoduodenectomy in Soft Pancreas: Randomized Controlled Trial', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:24.365290+00:00

Published At

2026-10-01T00:00:00+00:00

Record Updated At

2026-10-01

Source Retrieved At

2026-10-31T22:17:54.613222+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Pancreatic Cancer", "Periampullary Cancer", "Duodenal Cancer", "Cholangiocarcinoma", "Pancreatic Ductal Adenocarcinoma", "Pancreatic Head Mass", "Bile Duct Cancer"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-01", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT07155525"

protocolSection.identificationModule.officialTitle

"Pancreaticojejunostomy With or Without Modified N-butyl-2-cyanoacrylate Following Pancreaticoduodenectomy in Soft Pancreas: Randomized Controlled Trial"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["NA"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Pancreatic Cancer (protocolSection.conditionsModule.conditions)
• Periampullary Cancer (protocolSection.conditionsModule.conditions)
• Duodenal Cancer (protocolSection.conditionsModule.conditions)
• Cholangiocarcinoma (protocolSection.conditionsModule.conditions)
• Pancreatic Ductal Adenocarcinoma (protocolSection.conditionsModule.conditions)
• Pancreatic Head Mass (protocolSection.conditionsModule.conditions)
• Bile Duct Cancer (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Pancreaticojejunostomy with Modified N-Butyl-2-Cyanoacrylate (Glubran® 2)'], 'description': '* Standard duct-to-mucosa pancreaticojejunostomy performed\n* Application of 0.5-1.0 mL modified N-butyl-2-cyanoacrylate around the anastomotic site\n* Adhesive applied circumferentially around the pancreaticojejunal anastomosis\n* Allow 2-3 minutes for polymerization before proceeding\n* Standard placement of peritoneal drains', 'name': 'Pancreaticojejunostomy with Modified N-Butyl-2-Cyanoacrylate (Glubran® 2)', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Standard Pancreaticojejunostomy without tissue adhesive application.'], 'description': '* Patients undergo duct-to-mucosa pancreaticojejunostomy without additional adhesive following pancreaticoduodenectomy.\n* Standard placement of peritoneal drains\n* All other aspects of surgical care identical to experimental arm', 'name': 'Standard(duct-to-mucosa) Pancreaticojejunostomy', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• Pancreaticojejunostomy with Modified N-Butyl-2-Cyanoacrylate (Glubran® 2) (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.